Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.38 CHF | -0.42% |
|
-0.31% | +9.82% |
08:23am | Novartis Receives Health Canada Approval For Fabhalta Oral Treatment For Adult Patients With PNH | RE |
01:33am | NOVARTIS AG : UBS lowers his opinion and switches to Neutral | ZD |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- A poor 2024 increases the odds of a brighter 2025